% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • cynicoptimist cynicoptimist Jul 18, 2012 11:33 AM Flag

    Blue Sky Assessment

    The thing about NVIV is that you never know when the news hits. Its ok to trade around your core, but like PEM said on the other board, I would not want to sell any shares on a Friday. Anyway, they usually release their news in the morning before the market, but I have occasionally seen after market pm news.

    FDA approval I assume is random and can be released any hour of day. IMO, that will initiate at least a 50% increase in share price, which could then head higher still.

    Then when +++++ news comes from the clinicals, $5-$7.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Is $5-$7 pps after a +++ human clinical trial result a "low" estimate. There are several other milestones that could drive the stock to this level first--NASDAQ listing/announcement of approval of the clinical trials/opening of the manufacturing facility/possible take over bid by large pharmaceutical--can't believe that +++ human trial would only raise pps to this level

6.61-0.33(-4.76%)Sep 29 4:00 PMEDT